1. Anijs, Midas, Devanna, Paolo, Vernes, Sonja C. 2022. ARHGEF39, a Gene Implicated in Developmental Language Disorder, Activates RHOA and Is Involved in Cell De-Adhesion and Neural Progenitor Cell Proliferation. In Frontiers in molecular neuroscience, 15, 941494. doi:10.3389/fnmol.2022.941494. https://pubmed.ncbi.nlm.nih.gov/35959104/
2. Cooke, Mariana, Kreider-Letterman, Gabriel, Baker, Martin J, García-Mata, Rafael, Kazanietz, Marcelo G. . FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma. In Cell reports, 37, 109905. doi:10.1016/j.celrep.2021.109905. https://pubmed.ncbi.nlm.nih.gov/34731623/
3. Howarth, Karen D, Mirza, Tashfina, Cooke, Susanna L, Caldas, Carlos, Edwards, Paul A W. 2021. NRG1 fusions in breast cancer. In Breast cancer research : BCR, 23, 3. doi:10.1186/s13058-020-01377-5. https://pubmed.ncbi.nlm.nih.gov/33413557/
4. Huang, Yao, Zeng, Jianxing, Liu, Teng, Song, Xianglin, Zeng, Jinhua. 2024. ARHGEF39 targeted by E2F1 fosters hepatocellular carcinoma metastasis by mediating fatty acid metabolism. In Clinics and research in hepatology and gastroenterology, 48, 102446. doi:10.1016/j.clinre.2024.102446. https://pubmed.ncbi.nlm.nih.gov/39128592/
5. Gao, Jian, Jia, Wei-Dong. 2019. Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma. In Medical science monitor : international medical journal of experimental and clinical research, 25, 7826-7835. doi:10.12659/MSM.918270. https://pubmed.ncbi.nlm.nih.gov/31626606/
6. Xu, Baojin, Lv, Wu, Li, Xiaoyan, Zhang, Lina, Lin, Jie. 2019. Prognostic genes of hepatocellular carcinoma based on gene coexpression network analysis. In Journal of cellular biochemistry, 120, 11616-11623. doi:10.1002/jcb.28441. https://pubmed.ncbi.nlm.nih.gov/30775801/